David Ernest Burgio, Jr

Title: **The Innovative Mind of David Ernest Burgio, Jr.**

Introduction

David Ernest Burgio, Jr., an inventor based in Liberty Township, OH, has made significant strides in the pharmaceutical field with his impressive portfolio of six patents. His innovative work primarily focuses on improving the delivery and effectiveness of bisphosphonate therapies, which are crucial in treating conditions like osteoporosis. Through his inventions, he aims to enhance patient compliance and alleviate side effects associated with these treatments.

Latest Patents

Among his latest patents, David has developed oral dosage forms that include bisphosphonates such as risedronate. His inventive approach involves a unique combination of a chelating agent and a delayed release mechanism that targets the lower gastrointestinal tract. This method effectively minimizes the interaction between bisphosphonates and food or beverages, ensuring that the active ingredient remains available for absorption regardless of dietary intake. This advancement is crucial as it reduces the upper gastrointestinal irritation typically linked with bisphosphonate therapies, facilitating a more patient-friendly treatment regimen.

Another notable patent involves low dosage forms of risedronate or its salts. These formulations also incorporate a chelating agent and ensure the effective delivery of the bisphosphonate to the small intestine, enhancing absorption while allowing flexibility in consumption with or without food. This innovation not only simplifies complex treatment routines but is also essential in overcoming barriers that often lead to decreased patient adherence.

Career Highlights

David has gained extensive experience in the pharmaceutical industry, having worked with reputable companies such as Warner Chilcott Company, LLC and The Procter & Gamble Company. His tenure in these organizations has undoubtedly contributed to his expertise and innovative approach to pharmaceutical formulations and patient care.

Collaborations

Throughout his career, David has collaborated with various professionals, including Richard John Dansereau, who have played a role in advancing his research and inventions. These collaborative efforts emphasize the importance of teamwork in driving innovation within the pharmaceutical field.

Conclusion

David Ernest Burgio, Jr. continues to make waves in the realm of pharmaceuticals through his groundbreaking patents and research. His dedication to enhancing bisphosphonate therapy not only highlights his inventive spirit but also showcases his commitment to improving patient outcomes. As the industry evolves, David's contributions are poised to make a lasting impact on how bisphosphonates are administered and experienced by patients.